Coastline Trust Co Has $53,000 Holdings in The Chemours Company (NYSE:CC)

Coastline Trust Co lowered its stake in shares of The Chemours Company (NYSE:CC) by 48.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,150 shares of the specialty chemicals company’s stock after selling 2,960 shares during the period. Coastline Trust Co’s holdings in Chemours were worth $53,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. GAMMA Investing LLC grew its position in Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 765 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Chemours by 100.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 1,119 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new stake in Chemours during the fourth quarter worth $48,000. KBC Group NV boosted its position in Chemours by 38.2% in the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock worth $104,000 after purchasing an additional 1,708 shares during the last quarter. Finally, Sterling Capital Management LLC grew its stake in Chemours by 54.8% in the 4th quarter. Sterling Capital Management LLC now owns 8,453 shares of the specialty chemicals company’s stock valued at $143,000 after purchasing an additional 2,991 shares during the period. 76.26% of the stock is owned by institutional investors.

Chemours Price Performance

NYSE:CC opened at $11.37 on Friday. The stock has a fifty day moving average of $13.83 and a 200 day moving average of $17.31. The Chemours Company has a 52-week low of $9.33 and a 52-week high of $29.21. The firm has a market capitalization of $1.70 billion, a price-to-earnings ratio of 19.94 and a beta of 1.84. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68.

Chemours (NYSE:CC) last announced its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. On average, research analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a yield of 8.80%. Chemours’s payout ratio is 175.44%.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. The Goldman Sachs Group decreased their price objective on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. BMO Capital Markets dropped their price objective on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 19th. Barclays decreased their target price on Chemours from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 1st. Mizuho set a $15.00 price objective on Chemours in a research note on Tuesday. Finally, Morgan Stanley cut their target price on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, January 13th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Chemours currently has an average rating of “Moderate Buy” and an average price target of $21.56.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.